Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of CU-20101 versus BOTOX for moderate to severe glabellar lines
CTR20241540Phase 3Completed
- Sponsor
- CKD BiO
- Start
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of CU-20101 in glabellar furrowing, sponsored by CKD BiO. Started Jun 2024; status: completed.
02
Drugs
CU-20101
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20241540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241540.